NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ:OPHT) announced today that it has commenced an underwritten public offering of 1,900,000 shares of its common stock. In addition, certain stockholders of the company are expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional 285,000 shares of the company’s common stock at the public offering price, less the underwriting discount. Ophthotech will not receive any proceeds from the sale of shares by the selling stockholders. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.
Help employers find you! Check out all the jobs and post your resume.
